Group 1 - The announcement details the conversion of the company's convertible bonds in the first quarter of 2025, including the reduction in bond balance and the number of shares converted [8][9] - The company issued 7.38 million convertible bonds with a total value of 738 million yuan, each with a face value of 100 yuan, approved by the China Securities Regulatory Commission [2][3] - The initial conversion price of the convertible bonds was set at 21.50 yuan per share, which has undergone several adjustments due to stock repurchases and equity distributions, with the latest adjustment bringing it to 20.64 yuan per share [5][6][8] Group 2 - As of March 31, 2025, the remaining balance of the convertible bonds is 225,213,100 yuan, equivalent to 2,252,131 bonds [8] - The company reported a decrease of 11,000 yuan (110 bonds) in convertible bonds due to conversions, resulting in a total of 532 shares converted during the first quarter of 2025 [8]
上海科华生物工程股份有限公司关于2025年第一季度可转债转股情况的公告